AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2014
Nov 17, 2014
34129_dirs_2014-11-17_2d71309a-3a05-477b-84e1-eda54d387925.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-11-14
Reporting Person: Stein Kathryn E (Senior VP, Prd Dev & Reg Aff)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-14 | Common Stock | M | 23211 | $0.94 | Acquired | 66416 | Direct |
| 2014-11-14 | Common Stock | S | 23211 | $23.33 | Disposed | 43205 | Direct |
| 2014-11-17 | Common Stock | M | 2090 | $.94 | Acquired | 45295 | Direct |
| 2014-11-17 | Common Stock | S | 2090 | $22.95 | Disposed | 43205 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-14 | Stock Option (right to buy) | $0.94 | M | 23211 | Disposed | 2017-01-06 | Common Stock (23211) | Direct |
| 2014-11-17 | Stock Option (right to buy) | $0.94 | M | 2090 | Disposed | 2017-01-06 | Common Stock (2090) | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on 6/30/2014.
F2: The price reported in Column 4 is a weighted average price.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18